← Scroll for more →
Organogenesis Holdings Inc. (ORGO)
Pharmaceutical Preparations
Latest Price
$0.87
TTM P/E
--
Normalized P/E
--
TTM Div Yield
--
Fwd Div Yield
--
Book Value
1.15
P/B Ratio
0.76
Valuation metrics
adjust assumptions →EPS: $0.15
Book value / share: $2.36
Formula: √(22.5 × EPS × BVPS)
Graham Number
$2.82
+225% upside
Norm. op. income: $22M (median of 7yr)
Tax rate: 22%
Discount rate: 10%
Growth assumption: zero (EPV is a no-growth value)
Earnings Power Value
$1.58
+81% upside
Base FCF: $7M (median of recent 5yr)
Growth: -15%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$0.43
50% downside
EPS: $0.15
Target P/E: 15×
Formula: EPS × P/E
P/E Fair Value
$2.25
+159% upside
Institutional Ownership
50.7% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Morgan Stanley | 11.72M | $28.0M | 9.11% | +104.8K | 2026-06-30 |
| Soleus Capital Management, L.P. | 10.14M | $24.0M | 7.88% | +55.0K | 2026-06-30 |
| BlackRock, Inc. | 7.25M | $17.0M | 5.63% | +2.35M | 2026-06-30 |
| Dimensional Fund Advisors LP | 3.05M | $7.0M | 2.37% | +159.3K | 2026-06-30 |
| AQR Capital Management LLC | 3.01M | $7.0M | 2.34% | +2.13M | 2026-06-30 |
| Vanguard Capital Management LLC | 2.91M | $7.0M | 2.26% | +5.1K | 2026-06-30 |
| D. E. Shaw & Co., Inc. | 2.89M | $7.0M | 2.24% | +590.3K | 2026-06-30 |
| Assenagon Asset Management S.A. | 1.97M | $4.0M | 1.53% | -- | 2026-06-30 |
| Geode Capital Management, LLC | 1.94M | $4.0M | 1.50% | +151.6K | 2026-06-30 |
| Deutsche Bank AG\ | 1.71M | $4.0M | 1.33% | +505 | 2026-06-30 |